Chemomab Therapeutics Ltd Stock Statistic Functions Beta
| CMMB Stock | USD 1.62 0.12 6.90% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Chemomab Therapeutics correlated with the market. If Beta is less than 0 Chemomab Therapeutics generally moves in the opposite direction as compared to the market. If Chemomab Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chemomab Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chemomab Therapeutics is generally in the same direction as the market. If Beta > 1 Chemomab Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Chemomab Therapeutics Technical Analysis Modules
Most technical analysis of Chemomab Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Chemomab from various momentum indicators to cycle indicators. When you analyze Chemomab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Chemomab Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Chemomab Therapeutics Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chemomab Therapeutics Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Chemomab Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemomab Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Chemomab Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Chemomab Therapeutics, we also check how macroeconomic factors affect Chemomab Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Become your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 40 shares | |
 | Dividend Beast Invested over 30 shares | |
 | FinTech Invested over 50 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Investor Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Climate Change Invested over 90 shares | |
 | Technology Invested few shares | |
 | Impulse Invested few shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemomab Therapeutics Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemomab Therapeutics. Projected growth potential of Chemomab fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Chemomab Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Chemomab Therapeutics's market price often diverges from its book value, the accounting figure shown on Chemomab's balance sheet. Smart investors calculate Chemomab Therapeutics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Chemomab Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Chemomab Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemomab Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Chemomab Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.